Filing Details
Vor Biopharma Inc. (NASDAQ:VOR) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:VOR
Vor Biopharma Inc. (VOR) Files Quarterly Report for Q0
Vor Biopharma Inc. (NASDAQ:VOR) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
At publication ·
What changed
Vor Biopharma Inc. (NASDAQ:VOR) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Vor Biopharma Inc. (NASDAQ: VOR) filed its quarterly report (Form 10-Q) with the SEC on August 11, 2026.
- The company's stock trades at $23.59 with a market capitalization of $83.3 million.
- The 10-Q filing includes unaudited financial statements and management commentary on business performance, though specific revenue figures were not disclosed in this summary.
Market Context
Vor Biopharma Inc.'s stock currently trades at $23.59 with a market capitalization of $83.3M.
The 10-Q provides Vor Biopharma Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Vor Biopharma Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View VOR Stock Page
Frequently Asked Questions
Where can I read VOR's SEC filings?
Browse all filings on our VOR SEC filings page.
What types of SEC filings does Vor Biopharma Inc. file?
Public companies like Vor Biopharma Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.